US Patent Issued to Korea Institute of Oriental Medicine on Nov. 18 for "Composition for inhibiting osteoclasts containing agastache rugosa extract as active ingredient, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,221, issued on Nov. 18, was assigned to Korea Institute of Oriental Medicine (Daejeon, South Korea).

"Composition for inhibiting osteoclasts containing agastache rugosa extract as active ingredient, and use thereof" was invented by Hyun Il Ha (Daejeon, South Korea), Tae Soo Kim (Daejeon, South Korea), Youn Hwan Hwang (Daejeon, South Korea) and Seon A Jang (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The Agastache rugosa extract or the isoagastachoside or crude polysaccharide fraction included in the extract according to the present invention can be prepared based on plants being domestically cultivated, and thus is advantageous...